Shareable Research Card

AGEN - AGENUS INC Return On Equity

This metric view shows AGEN - AGENUS INC return on equity history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: 2025
Latest reported value
1%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2025
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: 2025.
  • Latest reported value on this page: 1%.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Return On Equity

New fact period available

Latest reported return on equity: 1%. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2025

Page type

Metric history

Latest period

2025

SEC-backed company facts were refreshed from filings filed on 20 Apr 2026.

Benchmark Context

How Return On Equity compares with peers

AGENUS INC is outside the visible top 120 companies for return on equity in the current sample.

Compared with

Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Return On Equity is down about 99% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Jun 2015 to 31 Mar 2026.
  • Nearby companies in this sample: Wellgistics Health, Inc. and XCF Global, Inc..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Financial Metric Page

AGENUS INC: Return On Equity

Latest period: 2025. Period end: 31 Dec 2025. Units: %. Frequency: annual and quarterly.

Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

What This Metric Tells You

  • Shows the reported level of return on equity over 30 Jun 2012 - 31 Dec 2025.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 26 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use annual sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 Wellgistics Health, Inc. (wgrx) 141760% Year - 31 Dec 2025 Open Wellgistics Health, Inc. Return On Equity
2 XCF Global, Inc. (safx) 77635% Year - 31 Dec 2025 Open XCF Global, Inc. Return On Equity
3 Cardiff Lexington Corp (cdix) 49573% Year - 31 Dec 2025 Open Cardiff Lexington Corp Return On Equity
4 Bionik Laboratories Corp. 46191% Quarter - 31 Mar 2023 Open Bionik Laboratories Corp. Return On Equity
5 Savara Inc (svra) 43610% Quarter - 31 Dec 2025 Open Savara Inc Return On Equity
6 Athenex, Inc. 25553% Quarter - 31 Dec 2022 Open Athenex, Inc. Return On Equity

Metric Details

Metric
Return On Equity (ROE)
Taxonomy
ratio
Units tracked
%
Frequency coverage
annual and quarterly
History range
30 Jun 2012 - 31 Dec 2025
Facts on this page
26
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)

AGENUS INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 1% -93% -99% 01 Jan 2025 31 Dec 2025
2024 94% -168% -64% 01 Jan 2024 31 Dec 2024
2023 262% 01 Jan 2023 31 Dec 2023
2017 355% +43989% 01 Jan 2017 31 Dec 2017
2016 -43634% -43509% -34799% 01 Jan 2016 31 Dec 2016
2015 -125% -37% -42% 01 Jan 2015 31 Dec 2015
2014 -88% -342% -135% 01 Jan 2014 31 Dec 2014
2013 254% +168% +196% 01 Jan 2013 31 Dec 2013
2012 86% 01 Jan 2012 31 Dec 2012

AGENUS INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2020 86% +24% +39% 01 Oct 2020 31 Dec 2020
Q3 2020 81% +2.8% +3.6% 01 Jul 2020 30 Sep 2020
Q2 2020 79% -0.82% -1% 01 Apr 2020 30 Jun 2020
Q1 2020 87% +20% +30% 01 Jan 2020 31 Mar 2020
Q4 2019 62% -60% -49% 01 Oct 2019 31 Dec 2019
Q3 2019 78% -58% -43% 01 Jul 2019 30 Sep 2019
Q2 2019 80% -54% -40% 01 Apr 2019 30 Jun 2019
Q1 2019 67% -72% -52% 01 Jan 2019 31 Mar 2019
Q4 2018 122% -37% -24% 01 Oct 2018 31 Dec 2018
Q3 2018 137% 01 Jul 2018 30 Sep 2018
Q2 2018 134% 01 Apr 2018 30 Jun 2018
Q1 2018 139% 01 Jan 2018 31 Mar 2018
Q4 2017 159% -165% -51% 01 Oct 2017 31 Dec 2017
Q4 2016 325% +449% 01 Oct 2016 31 Dec 2016
Q4 2015 -124% 01 Oct 2015 31 Dec 2015
Q3 2012 -1.9% 01 Jul 2012 30 Sep 2012
Q2 2012 -1.9% 01 Apr 2012 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .